Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft-versus-host disease

被引:3
作者
Wegner, Joanna [1 ]
Weidenthaler-Barth, Beate [1 ]
Engelbert, Julia [1 ]
Knothe, Max [2 ]
Braun, Claudia [1 ]
Helbig, Doris [3 ,4 ]
Sacher, Christopher [3 ,4 ]
Kreft, Andreas [5 ]
Wagner, Eva M. [6 ]
Ziemer, Mirjana [2 ]
Meyer, Ralf G. [6 ]
von Stebut, Esther [3 ,4 ]
机构
[1] Univ Med Ctr Mainz, Dept Dermatol, Mainz, Germany
[2] Univ Hosp Leipzig, Dept Dermatol, Leipzig, Germany
[3] Univ Cologne, Univ Hosp Cologne, Dept Dermatol, Cologne, Germany
[4] Univ Cologne, Fac Med Cologne, Cologne, Germany
[5] Univ Med Ctr Mainz, Dept Pathol, Mainz, Germany
[6] Univ Med Ctr Mainz, Dept Internal Med 3, Mainz, Germany
关键词
biomarker; graft-versus-host disease; immunohistochemistry; maculopapular drug eruption; Stevens-Johnson syndrome; toxic epidermal necrolysis; CONSENSUS DEVELOPMENT PROJECT; CLINICAL-TRIALS; NK CELLS; SKIN; CRITERIA; EXPRESSION; DEATH;
D O I
10.1111/exd.14416
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Graft-versus-host disease (GvHD) is a major complication following stem-cell or solid-organ transplantation. Accurate diagnosis of cutaneous GvHD is challenging, given that drug eruptions and viral rashes may present with similar clinical/histological manifestations. Specific markers are not available. We performed the histological examination of biopsy samples from acute GvHD (aGvHD; n = 54), Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN; n = 27), maculopapular drug eruption (MDE; n = 26) and healthy controls (n = 26). Samples of aGvHD showed a decrease in Langerhans cells (LC, p = 0.0001) and an increase in macrophages (M phi, p = 0.0001) compared to healthy skin. Compared to SJS/TEN, MDE and healthy skin, aGvHD biopsies contained greater numbers of CD4(+) and CD8(+) T cells. The majority of CD4(+) T-helper cells were localized in the upper dermis, whereas cytotoxic CD8(+) T cells were found in the epidermis. Increased numbers of CD56(+) natural killer (NK) cells in the upper dermis of aGvHD skin (p = 0.007) were not observed in controls or SJS/TEN and MDE. There were no differences in elafin staining between aGvHD and the latter two conditions. Acute GvHD appears to have a distinct inflammatory cell profile (T cells/NK cells) that may aid establishing in a more accurate diagnosis, especially when used to rule out differential diagnoses such as SJS/TEN or MDE.
引用
收藏
页码:1814 / 1819
页数:6
相关论文
共 32 条
[11]   Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow [J].
Heldal, D ;
Brinch, L ;
Evensen, SA ;
Tjonnfjord, GE ;
Aamodt, G ;
Elgjo, K ;
Sviland, L .
BONE MARROW TRANSPLANTATION, 2004, 34 (04) :345-350
[12]   The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation [J].
Hill, GR ;
Ferrara, JLM .
BLOOD, 2000, 95 (09) :2754-2759
[13]   Graft-versus-host disease of the skin: Life and death on the epidermal edge [J].
Hofmeister, CC ;
Quinn, A ;
Cooke, KR ;
Stiff, P ;
Nickoloff, B ;
Ferrara, JLM .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (06) :366-372
[14]   Graft-versus-host disease Part I. Pathogenesis and clinical manifestations of graft-versus-host disease [J].
Hymes, Sharon R. ;
Alousi, Amin M. ;
Cowen, Edward W. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) :515-534
[15]   Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease [J].
Jacobsohn, DA ;
Montross, S ;
Anders, V ;
Vogelsang, GB .
BONE MARROW TRANSPLANTATION, 2001, 28 (11) :1047-1051
[16]   Cytokine cascades in acute graft-versus-host disease [J].
Krenger, W ;
Hill, GR ;
Ferrara, JLM .
TRANSPLANTATION, 1997, 64 (04) :553-558
[17]   Biology of Graft-versus-Host Responses: Recent Insights [J].
MacDonald, Kelli P. ;
Shlomchik, Warren D. ;
Reddy, Pavan .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) :S10-S14
[18]   Utility of tissue elafin as an immunohistochemical marker for diagnosis of acute skin graft-versus-host disease: a pilot study [J].
Mahabal, G. D. ;
George, L. ;
Peter, D. ;
Bindra, M. ;
Thomas, M. ;
Srivastava, A. ;
Mathews, V. ;
George, B. ;
Pulimood, S. A. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (02) :161-168
[19]   A RETROSPECTIVE ANALYSIS OF THERAPY FOR ACUTE GRAFT-VERSUS-HOST DISEASE - INITIAL TREATMENT [J].
MARTIN, PJ ;
SCHOCH, G ;
FISHER, L ;
BYERS, V ;
ANASETTI, C ;
APPELBAUM, FR ;
BEATTY, PG ;
DONEY, K ;
MCDONALD, GB ;
SANDERS, JE ;
SULLIVAN, KM ;
STORB, R ;
THOMAS, ED ;
WITHERSPOON, RP ;
LOMEN, P ;
HANNIGAN, J ;
HANSEN, JA .
BLOOD, 1990, 76 (08) :1464-1472
[20]   Langerhans Cell Homeostasis and Turnover After Nonmyeloablative and Myeloablative Allogeneic Hematopoietic Cell Transplantation [J].
Mielcarek, Marco ;
Kirkorian, Anna Yasmine ;
Hackman, Robert C. ;
Price, Jeremy ;
Storer, Barry E. ;
Wood, Brent L. ;
Leboeuf, Marylene ;
Bogunovic, Milena ;
Storb, Rainer ;
Inamoto, Yoshihiro ;
Flowers, Mary E. ;
Martin, Paul J. ;
Collin, Matthew ;
Merad, Miriam .
TRANSPLANTATION, 2014, 98 (05) :563-568